Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024

Rhea-AI Summary

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company focused on digitizing surgeon-patient interfaces, has announced its plans to release 2024 second quarter financial and operating results after market close on Tuesday, August 13, 2024. The company will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide an update on the proposed merger with KARL STORZ.

Interested parties can access the call by dialing 1-800-717-1738 (domestic) or 1-646-307-1865 (international). A live audio webcast will also be available at https://ir.asensus.com/events-and-presentations, where a replay will be accessible after the call.

Positive

• Scheduled release of Q2 2024 financial results
• Upcoming investor conference call
• Potential merger with KARL STORZ to be discussed

Negative

• None.

RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release 2024 second quarter financial and operating results after the market closes on Tuesday, August 13, 2024. The Company will host a conference call to discuss these results and the status of the proposed merger with KARL STORZ starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial 1-800-717-1738 for domestic
callers and 1-646-307-1865 for international callers, approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link https://ir.asensus.com/events-and-presentations. The replay will be available on the Company’s website.

About Asensus Surgical, Inc.

Asensus Surgical is revolutionizing surgery with the first intra-operative Augmented Intelligence technology approved for use in operating rooms around the world. Recognized as an award-winning leader in digital technology, Asensus is committed to making surgery more accessible and predictable while delivering consistently superior outcomes. The Company’s novel approach to digitizing laparoscopy has led to system placements globally. Led by engineers, medical professionals, and industry luminaries, Asensus is powered by human ingenuity and driven by collaboration. To learn more about the Senhance® Surgical System and the new LUNA™ System in development, visit www.asensus.com.

Follow Asensus

Email Alerts: https://ir.asensus.com/email-alerts

LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc/

X: https://twitter.com/AsensusSurgical

YouTube: https://www.youtube.com/@AsensusSurgical

INVESTOR CONTACT:
Mark Klausner or Mike Vallie
ICR Westwicke
invest@asensus.com
443-213-0499

MEDIA CONTACT:
Dan Ventresca
Matter Communications
AsensusPR@matternow.com
617-874-5488

FAQ

When will Asensus Surgical (ASXC) release its Q2 2024 financial results?

Asensus Surgical (ASXC) will release its Q2 2024 financial results after market close on Tuesday, August 13, 2024.

What time is Asensus Surgical's (ASXC) Q2 2024 earnings call scheduled for?

Asensus Surgical's (ASXC) Q2 2024 earnings call is scheduled for 4:30 p.m. ET on Tuesday, August 13, 2024.

How can investors access Asensus Surgical's (ASXC) Q2 2024 earnings call?

Investors can access Asensus Surgical's (ASXC) Q2 2024 earnings call by dialing 1-800-717-1738 (domestic) or 1-646-307-1865 (international), or via webcast at https://ir.asensus.com/events-and-presentations.

What topics will be discussed in Asensus Surgical's (ASXC) upcoming earnings call?

Asensus Surgical's (ASXC) upcoming earnings call will discuss Q2 2024 financial and operating results, as well as provide an update on the proposed merger with KARL STORZ.